Last quarter (Q ), One World Pharma's total revenue was $5.91K, a decrease of -82.30% from the same quarter last year. In Q, One World Pharma's net income was $-450.31K. See One World Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 58.36K	$ 125.66K	$ 65.26K	$ 59.57K	$ 0.00	$ 0.00
Cost of Revenue	$ 357.39K	$ 300.76K	$ 19.74K	$ 104.73K	$ 0.00	-
Gross Profit	$ -189.50K	$ -175.09K	$ 45.52K	$ -45.16K	$ 0.00	-
Operating Expense	$ 4.97M	$ 2.06M	$ 3.25M	$ 7.87M	$ 5.72M	$ 26.96K
Operating Income	$ -2.03M	$ -2.24M	$ -3.20M	$ -7.92M	$ -5.72M	$ -26.96K
Net Non Operating Interest Income Expense	$ -247.19K	$ -956.82K	$ -508.77K	$ -47.59K	$ -382.58K	-
Other Income Expense	$ -189.37K	$ -132.48K	$ 82.96K	$ 47.59K	$ -106.09K	-
Pretax Income	$ -2.09M	$ -3.06M	$ -3.80M	$ -7.97M	$ -6.21M	$ -26.96K
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	$ -11.48K	$ 0.00	-	-
Net Income Common Stockholders	$ -2.13M	$ -3.08M	$ -3.86M	$ -9.50M	$ -6.21M	$ -26.96K
Basic EPS	$ -0.06	$ -0.05	$ -0.06	-	$ -0.15	$ -0.02
Diluted EPS	$ -0.04	$ -0.05	$ -0.06	$ -0.20	$ -0.15	$ -0.02
Basic Average Shares	$ 280.43M	$ 66.19M	$ 60.60M	$ 48.83M	$ 41.09M	$ 1.32M
Diluted Average Shares	$ 280.43M	$ 66.19M	$ 60.60M	$ 48.83M	$ 41.09M	$ 1.32M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 5.33M	$ 2.36M	$ 3.27M	$ 7.98M	$ 5.72M	$ 26.96K
Net Income From Continuing And Discontinued Operation	$ -2.09M	$ -3.06M	$ -3.80M	$ -7.97M	$ -6.21M	$ -26.96K
Normalized Income	$ -1.05M	$ -2.41M	-	-	$ -6.10M	$ -26.96K
Interest Expense	-	-	-	-	$ 382.58K	-
EBIT	$ -1.85M	$ -2.10M	$ -3.29M	$ -7.92M	$ -5.82M	$ -26.96K
EBITDA	$ -1.79M	$ -1.48M	$ -3.25M	$ -7.88M	$ -5.80M	$ -26.96K

Currency in USD

One World Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing